Boswellia extract calms inflammation through routes different from common anti-inflammatory drugs. Its best-supported use is easing knee osteoarthritis pain and stiffness, with modest improvement after a few weeks. A smaller body of work suggests better blood-sugar and cholesterol markers. It is well tolerated, mainly causing mild digestive complaints. (Full Review)

Protocol

Standard oral dose

300–400 mg, 2–3×/day

Standardized extract (30–65% boswellic acids), roughly 600–1200 mg/day total

Enhanced-bioavailability forms

100–250 mg, 1–2×/day

Branded extracts (e.g., 5-Loxin, Aflapin, lecithin-delivery) deliver more AKBA per mg

Dosing schedule

Split, with a fat-containing meal

Split dosing preferred over a single large dose; pairing with meals is the key timing consideration

Time to effect

Osteoarthritis symptom relief

1–4 weeks

Begins after about 1–4 weeks of consistent use; some standardized extracts report earlier onset

Fair trial period

4–8 weeks

At least 4–8 weeks before judging effectiveness

Minimum duration for benefit

~4 weeks

A minimum treatment duration of about four weeks is needed for benefit

Benefits

High: Knee osteoarthritis symptom relief

Medium: Improved glycemic and lipid markers in type 2 diabetes; reduced joint inflammation beyond symptom scores

Low: Inflammatory bowel disease symptom control; asthma and airway inflammation

Speculative: Anti-cancer and peritumoral edema effects; general longevity and healthspan effects

Contraindications

Pregnancy and breastfeeding

Known resin/plant allergy

High-intensity anticoagulation

Key Interactions

Prescription anti-inflammatories and immunosuppressants (NSAIDs e.g. ibuprofen, naproxen; leukotriene-modifying asthma drugs e.g. montelukast, zileuton)

Anticoagulants and antiplatelet drugs (warfarin, direct oral anticoagulants e.g. apixaban, rivaroxaban; antiplatelet agents e.g. aspirin, clopidogrel)

CYP450-metabolized drugs (CYP3A4 or CYP2C9 substrates e.g. statins, certain blood thinners)

Over-the-counter medications (OTC NSAIDs e.g. ibuprofen, aspirin; antacids)

Supplement interactions (curcumin, omega-3 fatty acids, ginger; antiplatelet supplements e.g. high-dose fish oil, garlic, ginkgo)

Risk & Side Effects

High: Favorable overall safety / mild gastrointestinal upset

Medium: Skin reactions and allergic hypersensitivity

Low: Theoretical pro-menstrual / uterine stimulant effect

Speculative: Liver enzyme effects with high-dose or prolonged use; bleeding risk via anti-platelet activity

Monitoring

Marker	Target	Why
hs-CRP	< 1.0 mg/L	Tracks systemic inflammation the extract aims to lower
HbA1c (glycated hemoglobin)	< 5.4%	Tracks 3-month blood-sugar control if used for metabolic benefit
Lipid panel (total cholesterol, LDL, HDL, triglycerides)	LDL < 100 mg/dL; triglycerides < 100 mg/dL; HDL > 50 mg/dL	Detects the cholesterol-lowering effect seen in diabetic trials
ALT/AST	ALT < 25 U/L (functional); within conventional reference range	Screens for the theoretical liver effect with high-dose or prolonged use

Cadence: Reassess symptoms at about 4 and 8 weeks; for metabolic or higher-dose long-term use, recheck relevant labs every 3–6 months, then every 6–12 months once stable

Qualitative Assessment

Joint pain intensity and morning stiffness duration
Physical function and mobility (e.g., walking distance, stair climbing)
Reliance on rescue analgesics (a drop signals benefit)
General energy levels and quality of sleep disrupted by pain

Boswellia Extract for Health & Longevity

Protocol

Benefits

Risk & Side Effects

Monitoring

Qualitative Assessment